Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Haliotis T, Roder J, Dexter D: Evidence for in vivo NK reactivity against primary tumors. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, pp 1399–1404
   Google Scholar
2. Trentin JJ, Datta SK, Priest EL, Gallagher MT, Nasrallah AG: Transfer of NK activity and lymphoma resistance to AKR mice by marrow from high NK, lymphoma-resistant (C57 × AKR) F1 mice. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, pp 1405–1409
   Google Scholar
3. Stutman O, Cuttito MJ: Genetic control of NC activity in the mouse: Three genes located in chromosome 17. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, pp 281–289
   Google Scholar
4. Carlson GA, Greenberg A: Approaches to the genetic analysis of natural resistance in vivo. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, 291–299
   Google Scholar
5. Herberman RB, Ortaldo JR: Natural killer cells: Their role in defenses against disease. Science 214: 24–30, 1981
   PubMed Google Scholar
6. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR: Role of NK cells in tumor growth and metastasis in beige mice. Nature 284: 622–624, 1980
   PubMed Google Scholar
7. Roder JC, Haliotis T, Klein M, Korec S, Jett JR, Ortaldo J, Herberman RB, Katz P, Fauci AS: A new immunodeficiency disorder in humans involving NK cells. Nature 284: 553–555, 1980
   PubMed Google Scholar
8. Lipinski M, Tursz T, Kreis H, Finale Y, Amiel JL: Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy. Transplantation 29: 214–218, 1980
   PubMed Google Scholar
9. Greene MH, Hoover RN, Fraumeni JF: Subsequent cancer in patients with chronic lymphocytic leukemia — a possible immunologic mechanism. J Natl Cancer Inst 61: 337–340, 1978
   PubMed Google Scholar
10. Ziegler HW, Kay NE, Zarling JM: Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia. Int J Cancer 27: 321–327, 1981
    PubMed Google Scholar
11. Strayer DR, Carter WA, Mayberry SD, Pequignot E, Brodsky I: Low natural cytotoxicity of peripheral mono-nuclear cells in individuals with high familial incidences of cancer. Cancer Res 44: 370–374, 1984
    PubMed Google Scholar
12. Cunningham-Rundles S, Filippa DA, Braun DW, Antonelli P, Ashikari H: Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst 67: 585–590, 1981
    PubMed Google Scholar
13. Fulton A, Heppner G, Roi L, Howard L, Russo J, Brennan M: Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer. Breast Cancer Res Treat 4: 109–116, 1984
    PubMed Google Scholar
14. Lipinski M, Dokhelar M-C, Tursz T: NK cell activity in patients with high risk for tumors and in patients with cancer. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, pp 1183–1187
    Google Scholar
15. Hersey P, Edwards A, Honeyman M, McCarthy WH: Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40: 113–122, 1979
    PubMed Google Scholar
16. Zarling JM, Eskra L, Borden EC, Horoszewicz JS, Carter WA: Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. J Immunol 123: 63–70, 1979
    PubMed Google Scholar
17. Ortaldo J, Herberman R, Pestka S: Augmentation of human natural killer cells with human leukocyte and human recombinant leukocyte interferon. In: Herberman RB (ed): NK Cells and Other Natural Effector Cells. Academic Press, New York, 1982, pp 349–354
    Google Scholar
18. Henney CS, Kuribayashi K, Kern DE, Gillis S: Interleukin-2 augments natural killer cell activity. Nature 291: 335–338, 1981
    PubMed Google Scholar
19. Kuribayashi K, Gillis S, Kern DE, Henney CS: Murine NK cell cultures: Effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. J Immunol 126: 2321–2327, 1981
    PubMed Google Scholar
20. Goldfarb RH, Herberman RB: Natural killer cell reactivity: Regulatory interactions among phorbol ester, interferon, cholera toxin, and retinoic acid. J Immunol 126: 2129–2135, 1981
    PubMed Google Scholar
21. Droller MJ, Schneider MU, Perlmann P: A possible role of prostaglandins in the inhibiton of natural and antibody dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol 39: 165–177, 1978
    PubMed Google Scholar
22. Winer BJ: Statistical Principles in Experimental Design (2nd ed). McGraw-Hill, New York, 1971, pp 402–404
    Google Scholar

Download references